Blood collected from donors can be stored and transfused in an unmodified state, referred to as whole blood transfusion. However, if processed, the collected blood can be of use to more than one patient. According to the World Health Organization (WHO) 2016 estimates, only 43% of the blood collected in low-income countries is separated into different components such as plasma, red cell concentrates, and platelet concentrates. The rate is much higher (96%) in high-income countries such as U.S., Germany, U.K., and France. Lack of adequate test kits, blood processing devices and infrastructure are some of the factors responsible for low rate of blood processing in low-income countries.
Download PDF Brochure Of This Research Report @ https://www.coherentmarketinsights.com/insight/request-pdf/83
Increasing number of blood transfusion procedures is augmenting the global blood processing devices and consumables market size
Blood transfusion is a process required to make up for the lost blood during a surgery or due to an injury or a disease. According to the American National Red Cross, a humanitarian organization, around 21 million blood components are transfused every year in the U.S. Blood transfusion is a frequent process in sickle cell patients. The sickle cell disease affects 90,000 to 100,000 people in the U.S., as per the American National Red Cross.
Demand for blood processing devices and consumables is growing rapidly with establishment of new hospitals and blood banks, and increasing number of blood transfusion procedures. Asia Pacific is one of the most lucrative blood processing devices and consumables market. According to the Friends2support organization, a non-profit organization allowing patient access to blood donors, around 30 million blood components are transfused every year in India.
Need for blood processing devices and consumables is projected to continue along an upward growth trajectory, owing to increasing number of blood banks and growing incidence of blood infection and blood disorders. Moreover, number of blood transfusion surgical procedures is increasing due to increasing incidence of immunodeficiency diseases.
For instance, according to the 2016 World Health Organization (WHO) statistics, around 112.5 million units of donated blood are collected every year, globally. The WHO recommends implementation of a national blood policy to ensure maintaining quality (free from infection) of the blood collected. This in turn ensures consistent demand for blood processing devices and consumables globally.
Inquire Here Before Purchase of Research Report @ https://www.coherentmarketinsights.com/insight/talk-to-analyst/83
Key companies covered as a part of this study include Abbott Laboratories, Becton, Dickinson And Company, Roche Holdings AG, Bio-Rad Laboratories, Biomerieux SA, Immucor, Inc., Danaher Corporation, Terumo Corporation, Macopharma SA, Grifols International, Haemonetics Corporation, and Thermogenesis Corporation
About Coherent Market Insights
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
Subscribe to our newsletter to get notification about new updates,information, discount, etc..